Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention
批准号:
10680493
负责人:
Ji-Yong Julie Kim
金额:
$62.75万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-07-01 至 2025-06-30
关键词:
3-DimensionalAdipocytesAdipose tissueAffectBenignBiological ModelsCell CountCellsChIP-seqCoculture TechniquesDNA MethylationDevelopmentDiagnosisDiseaseEndometrialEndometrial CarcinomaEndometrial NeoplasmsEndometrial adenocarcinomaEndometriumEnvironmentEpigenetic ProcessEpithelial CellsEstrogensFOXO1A geneFosteringGene ExpressionGenesGenomicsGoalsGrowthHistonesHormonesHumanIn VitroIncidenceMalignant Female Reproductive System NeoplasmMalignant NeoplasmsMenstrual cycleMetforminMicrofluidicsModernizationMolecularObesityOrganOrganoidsPathway interactionsPatientsPhenotypePremenopauseProcessProgesteroneProgesterone ReceptorsProto-Oncogene Proteins c-aktPublic HealthResearchResistanceRiskRisk FactorsRoleSample SizeSignal TransductionStromal CellsSystemTechnologyTestingTimeTissuesWomanWorkbisulfite sequencingcarcinogenesisdeep sequencingendometrial cancer preventionendometrial organoidepigenomegenome-wide analysishigh riskhigh risk populationin vitro Modelinhibitorinnovative technologiesinsightmicrofluidic technologyobese personpermissivenesspreventprotective effectreceptorrelease factorresponsesingle-cell RNA sequencingtheoriestranscriptometumortumorigenesistumorigenicwhole genome
中文摘要
子宫内膜癌的发病率每年都在上升,2018年美国新增病例超过6万例。肥胖仍然是一个重大的公共卫生问题,是发生子宫内膜癌的主要危险因素。尽管来自脂肪组织的过量雌激素被认为使女性易患子宫内膜癌,但黄体酮在肥胖中的保护作用尚不清楚。研究表明,肥胖女性雌激素过量的理论并不总是正确的,特别是在绝经前的状态。我们假设脂肪组织释放因子激活子宫内膜上皮细胞中AKT通路,从而减弱孕酮受体(PR)的作用,从而增加子宫内膜瘤变的风险。在这项研究中,我们将在微流体系统中使用三维球体培养来破译PR在存在或不存在脂肪细胞的人子宫内膜中的作用。这些创新技术使我们能够首次研究脂肪细胞对影响黄体酮敏感性的信号传导和基因组活动的影响。我们将确定脂肪细胞如何影响黄体酮驱动的子宫内膜类器官的分化和存活,以及表观遗传学的变化,包括DNA甲基化和组蛋白标记,如何影响ER和PR细胞。无偏测序将使用允许对小细胞数量进行深度测序的技术。这项研究将深入了解可能导致肿瘤发生的早期变化,这将有助于确定如何有效地预防高危肥胖妇女的子宫内膜癌。
英文摘要
The incidence of endometrial cancer is on the rise each year reaching over 60,000 new cases in the US in 2018. Obesity remains a significant public health problem and is a major risk factor for developing endometrial cancer. Although excess estrogen from adipose tissues is thought to predispose a woman from developing endometrial cancer, the protective role of progesterone in obesity is unknown. Studies demonstrate that the excess estrogen theory in obese women does not always hold true particularly in the premenopausal state. We hypothesize that adipose tissue release factors that activate the AKT pathway in endometrial epithelial cells to blunt progesterone receptor (PR) action, thereby increasing the risk of endometrial neoplasia. In this study, we will decipher the actions of PR in the human endometrium in the presence or absence of adipocytes using 3D spheroid cultures in microfluidic systems. These innovative technologies allow us to study for the first time, the effect of adipocytes on the signaling and genomic activities that affect progesterone sensitivity. We will determine how adipocytes affect progesterone driven differentiation and survival of the endometrial organoids and how changes in epigenetics, including DNA methylation and histone marks, affect the ER and PR cistrome. Unbiased sequencing will be done using technologies that allow for deep sequencing of small cell numbers. This research will generate insight into the early changes that may lead to tumorigenesis which will be useful to determine how to effectively prevent endometrial cancer in the obese women who are at high risk.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.ajog.2020.06.004
发表时间:
2020-11
期刊:
American journal of obstetrics and gynecology
影响因子:
9.8
作者:
[Critchley HOD, Babayev E, Bulun SE, Clark S, Garcia-Grau I, Gregersen PK, Kilcoyne A, Kim JJ, Lavender M, Marsh EE, Matteson KA, Maybin JA, Metz CN, Moreno I, Silk K, Sommer M, Simon C, Tariyal R, Taylor HS, Wagner GP, Griffith LG]
通讯作者:
Griffith LG
Microphysiological modeling of Endometriosis
-
批准号:10816913
-
项目类别:
-
资助金额:$56.24万
-
财政年份:2023
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Reactive Oxygen Species in the Initiation, Survival and Racial Disparity of Uterine Leiomyoma
-
批准号:10231239
-
项目类别:
-
资助金额:$61.98万
-
财政年份:2020
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Project 01: Understanding Racial Disparity in Endometrial Cancer through Tumor Genomics
-
批准号:10265427
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2020
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Reactive Oxygen Species in the Initiation, Survival and Racial Disparity of Uterine Leiomyoma
-
批准号:10410463
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2020
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Project 01: Understanding Racial Disparity in Endometrial Cancer through Tumor Genomics
-
批准号:10488638
-
项目类别:
-
资助金额:$25.23万
-
财政年份:2020
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Reactive Oxygen Species in the Initiation, Survival and Racial Disparity of Uterine Leiomyoma
-
批准号:10655328
-
项目类别:
-
资助金额:$45.96万
-
财政年份:2020
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Northwestern Center for Reproductive Science Predoctoral Training Program in Reproductive Science, Medicine, and Technology
-
批准号:10401464
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention
-
批准号:10221650
-
项目类别:
-
资助金额:$53.16万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Northwestern Center for Reproductive Science Predoctoral Training Program in Reproductive Science, Medicine, and Technology
-
批准号:10163063
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive Platform
-
批准号:10432418
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Northwestern Center for Reproductive Science Predoctoral Training Program in Reproductive Science, Medicine, and Technology
-
批准号:10622484
-
项目类别:
-
资助金额:$20.57万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive Platform
-
批准号:10017982
-
项目类别:
-
资助金额:$118.17万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive Platform
-
批准号:10256811
-
项目类别:
-
资助金额:$118.17万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Northwestern Center for Reproductive Science Predoctoral Training Program in Reproductive Science, Medicine, and Technology
-
批准号:9926905
-
项目类别:
-
资助金额:$19.37万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention
-
批准号:10430077
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2019
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Influence of AKT pathway on progesterone receptor function in endometrial cancer
-
批准号:9038319
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2012
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Influence of AKT pathway on progesterone receptor function in endometrial cancer
-
批准号:8628078
-
项目类别:
-
资助金额:$30.72万
-
财政年份:2012
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Influence of AKT pathway on progesterone receptor function in endometrial cancer
-
批准号:8479324
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2012
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Project 2: Molecular and Functional Crosstalk of Progesterone Receptor
-
批准号:8308000
-
项目类别:
-
资助金额:$40.49万
-
财政年份:2011
-
负责人:Ji-Yong Julie Kim
-
依托单位:
Project 2: Molecular and Functional Crosstalk of Progesterone Receptor
-
批准号:8099639
-
项目类别:
-
资助金额:$41.41万
-
财政年份:2010
-
负责人:Ji-Yong Julie Kim
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: